Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients-authors' response.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mingyao,Sun

第一单位： Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou, Gansu, China.;Department of Intensive Care Unit, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.

作者： Mingyao,Sun ^[1] ; Honghao,Lai ^[2] ; Zhigang,Zhang ^[1] ; Long,Ge ^[3]

作者单位： Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou, Gansu, China.;Department of Intensive Care Unit, The First Hospital of Lanzhou University, Lanzhou, Gansu, China. ^[1] Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, Gansu, China.;Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, Gansu, China. ^[2] Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, Gansu, China.;Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, Gansu, China.;Key Laboratory of Evidence-Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, Gansu, China. ^[3]

主题词人类(Humans);随机对照试验(主题)(Randomized Controlled Trials as Topic);羟胺类(Hydroxylamines)

DOI 10.1093/jac/dkad336

PMID 37883699

发布时间 2024-07-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交